Hematological indices as predictors of in-hospital adverse outcomes in patients with COVID-19.
4 affiliations
- 1Programa de Pós-Graduação em Medicina Tropical, Universidade Federal de Pernambuco, Recife, PE, Brasil.
- 2Hospital das Clínicas, Universidade Federal de Pernambuco/Empresa Brasileira de Serviços Hospitalares, Recife, PE, Brasil.
- 3Centro de Ciências Médicas, Universidade Federal de Pernambuco, Recife, PE, Brasil.
- 4Instituto Aggeu Magalhães, Fiocruz, Recife, PE, Brasil.
Abstract
The SARS-CoV-2 pandemic required medical teams to make rational decisions with limited resources, especially in Brazil. Various diagnostic tools, clinical guidelines, and existing indices were adopted to predict the risk of death and other adverse outcomes. The objective of this study was to validate three hematological indices [neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and lymphocyte-monocyte ratio (LMR)] for predicting adverse hospital outcomes in patients with COVID-19 in an observational cohort at a hospital in northeastern Brazil between April 2020 and October 2021. Hematological indices were calculated based on admission blood counts and correlated with hospital outcomes: in-hospital death, invasive mechanical ventilation, and renal replacement therapy. The analysis determined the frequencies of outcomes, established index thresholds, and assessed their association and accuracy and factors associated with hospital survival. Intra-hospital outcomes reflected disease severity; 34.62% of patients required admission to the ICU, 26.21% invasive mechanical ventilation, 4.2% renal replacement therapy, and 21.04% died. Advanced age, ICU requirement, and higher NLR were associated with higher risk of death. Multivariate analysis identified NLR as the only index associated with worse prognosis, with a cutoff point of 5.24 at hospital admission, showing a sensitivity of 84.0% and accuracy of 86.9%. The negative predictive value of 95.52% was highly significant, assisting hospital management by focusing efforts on higher-risk patients. These findings highlight the predictive value of the NLR, PLR, and LMR indices as valuable markers for risk stratification in patients hospitalized with COVID-19, offering a broader view of prognosis and guiding more personalized management and care strategies.
Related
- Inflammatory Hematological Indices in Heart Failure with Preserved Ejection Fraction: Associations with Disease Severity and 12-Month Outcomes
- Hematological inflammatory markers as predictors of atherosclerotic progression in patients with psoriasis: A retrospective case–control study from the SH-YIMED database
- Predictive value of baseline hematological and platelet indices for visual and anatomical outcomes in retinal vein occlusion: a retrospective analysis.
- Health literacy and self-efficacy as predictors of self-care behaviors in patients with hematological malignancies: A multicenter cross-sectional study in northeastern Thailand.
- Prehospital predictors of clinical outcomes in out-of-hospital cardiac arrest with pulseless electrical activity: a JCS-ReSS report
BibTeX
@article{pordeus2026hematological,
title = {{Hematological indices as predictors of in-hospital adverse outcomes in patients with COVID-19.}},
author = {E B Pordeus and N A Filgueira and C R P Soares and P S R de Araújo},
journal = {Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas},
year = {2026},
month = oct,
doi = {10.1590/1414-431x2026e15557},
url = {https://europepmc.org/article/MED/42879641},
note = {CC BY},
}
RIS
TY - JOUR
TI - Hematological indices as predictors of in-hospital adverse outcomes in patients with COVID-19.
AU - E B Pordeus
AU - N A Filgueira
AU - C R P Soares
AU - P S R de Araújo
PY - 2026
DA - 2026/10/12
JO - Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
DO - 10.1590/1414-431x2026e15557
UR - https://europepmc.org/article/MED/42879641
AB - The SARS-CoV-2 pandemic required medical teams to make rational decisions with limited resources, especially in Brazil. Various diagnostic tools, clinical guidelines, and existing indices were adopted to predict the risk of death and other adverse outcomes. The objective of this study was to validate three hematological indices [neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and lymphocyte-monocyte ratio (LMR)] for predicting adverse hospital outcomes in patients with COVID-19 in an observational cohort at a hospital in northeastern Brazil between April 2020 and October 2021. Hematological indices were calculated based on admission blood counts and correlated with hospital outcomes: in-hospital death, invasive mechanical ventilation, and renal replacement therapy. The analysis determined the frequencies of outcomes, established index thresholds, and assessed their association and accuracy and factors associated with hospital survival. Intra-hospital outcomes reflected disease severity; 34.62% of patients required admission to the ICU, 26.21% invasive mechanical ventilation, 4.2% renal replacement therapy, and 21.04% died. Advanced age, ICU requirement, and higher NLR were associated with higher risk of death. Multivariate analysis identified NLR as the only index associated with worse prognosis, with a cutoff point of 5.24 at hospital admission, showing a sensitivity of 84.0% and accuracy of 86.9%. The negative predictive value of 95.52% was highly significant, assisting hospital management by focusing efforts on higher-risk patients. These findings highlight the predictive value of the NLR, PLR, and LMR indices as valuable markers for risk stratification in patients hospitalized with COVID-19, offering a broader view of prognosis and guiding more personalized management and care strategies.
SN - 0100-879X
SN - 1414-431X
ER -